Nicotine Dependence
📧 Sign up to get email alerts when something new happens for Nicotine Dependence.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Unraveling the Genetic Basis of Nicotine Addiction for Novel Therapeutic Strategies
This clinical trial aims to unravel the genetic basis of nicotine addiction to guide the development of new therapeutic strategies and is cu…
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: Biopsychosocial Predictors of Nicotine Relapse [NA]
The University of Cyprus is conducting a study to identify biopsychosocial predictors of nicotine relapse in people attempting smoking cessa…
-
CLINICAL_TRIALS research · 2024-06-05Clinical Trial Update: Development of a Smoking Cessation Video Series [NA]
A clinical trial update notes recruitment for a study developing a smoking cessation video series to support cessation efforts.
-
CLINICAL_TRIALS research · 2024-06-05Clinical Trial Update: Impact of Aversive Warnings on E-Cigarette Cessation [Phase 3]
A Phase 3 clinical trial from University of California, San Diego is evaluating the impact of aversive warnings on e-cigarette cessation; th…
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: Nicotine Withdrawal Symptoms and Smoking Relapse [NA]
This completed clinical trial evaluated nicotine withdrawal symptoms and smoking relapse in people with nicotine dependence. Results have be…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt [NA]
A completed study from Wake Forest evaluated transcranial magnetic stimulation to help reduce smoking in individuals after a quit attempt; r…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Efficacy and Safety of E-cigarettes for Smoking Cessation in Middle-aged Heavy Smokers [Phase 4]
Phase 4 clinical trial completed evaluating the efficacy and safety of electronic cigarettes for smoking cessation in middle-aged heavy smok…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Cigarette Consumption After switchinG to High or Low Nicotine strENght E-cigaretteS In Smokers With Schizophrenia [NA]
A clinical trial evaluating whether switching to high- or low-nicotine strength electronic cigarettes affects cigarette consumption in peopl…
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Effects of Exercise and Nicotine on Cognition in Smokers [Phase 3]
A Phase 3 clinical trial completed evaluating whether exercise and nicotine affect cognitive performance in smokers seeking smoking cessatio…
-
CLINICAL_TRIALS research · 2024-05-02Clinical Trial Update: Financial Incentives for Smoking Treatment II [NA]
UCLA is conducting a trial evaluating financial incentives to support smoking cessation, with enrollment currently by invitation only.
-
FDA approval · 2024-04-30FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE (nicotine polacrilex) submitted by Haleon US Holdings LLC.
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: CSD201001: Study to Assess Elements of Abuse Liability for Three Nicotine Pouches [NA]
Clinical trial update indicates completion of a study to assess abuse liability for three nicotine pouch products sponsored by RAI Services …
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Nicotine Pharmacokinetics Following Use of the P4M3 Gen 2.0 E-Cigarette Compared to Smoking Cigarettes [NA]
The study evaluated nicotine pharmacokinetics after using the P4M3 Gen 2.0 e-cigarette compared with traditional cigarette smoking, with res…
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: Behavioral Pharmacology of Cannabis and Nicotine [Phase 1]
Phase 1 study update on the behavioral pharmacology of cannabis and nicotine conducted by Johns Hopkins University; results posted after com…
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: Varenicline For Nicotine Vaping Cessation In Non Smoker Vaper Adolescents [Phase 4]
Phase 4 trial investigating varenicline for nicotine vaping cessation in non-smoker vaper adolescents was terminated; results posted.
-
FDA approval · 2024-03-15FDA Approved: QUITINE NICOTINE — Supplemental Application (QUITINE LLC)
FDA approved a supplemental application for QUITINE NICOTINE (nicotine polacrilex) from QUITINE LLC.
-
FDA approval · 2024-03-15FDA Approved: FOSTER AND THRIVE NICOTINE — Supplemental Application (Strategic Sourcing Services LLC)
The FDA approved a supplemental application for Foster and Thrive Nicotine (nicotine polacrilex) submitted by Strategic Sourcing Services LL…
-
FDA approval · 2024-03-15FDA Approved: EQUATE NICOTINE — Supplemental Application (Wal-Mart Stores Inc)
The FDA approved a supplemental application for EQUATE NICOTINE (nicotine polacrilex) submitted by Wal-Mart Stores Inc.
-
FDA approval · 2024-03-15FDA Approved: GOOD NEIGHBOR PHARMACY NICOTINE — Supplemental Application (Amerisource Bergen)
FDA approved a supplemental application for Good Neighbor Pharmacy Nicotine (nicotine polacrilex) under ANDA076789, representing an approved…
-
FDA approval · 2024-03-15FDA Approved: BASIC CARE NICOTINE — Supplemental Application (Amazon.com Services LLC)
FDA approved a supplemental application for BASIC CARE NICOTINE (nicotine polacrilex) submitted by Amazon.com Services LLC.
-
FDA approval · 2024-03-15FDA Approved: NICOTINE — Supplemental Application (H E B)
FDA approves a supplemental application for NICOTINE (nicotine polacrilex) from H E B, indicating an updated label or additional use for thi…
-
FDA approval · 2024-03-15FDA Approved: GOOD SENSE NICOTINE — Supplemental Application (L. Perrigo Company)
The FDA approved a supplemental application for Good Sense Nicotine (nicotine polacrilex) by L. Perrigo Company. This action confirms an upd…
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: Reduced HPHC Exposure in Cigarette Smokers Switching to P4M3 Gen. 2.0 Compared to Continuing Smoking, or Smoking Abstinence [NA]
A completed clinical trial examining reduced exposure to HPHC in cigarette smokers who switch to P4M3 Gen. 2.0 compared with continuing smok…
-
FDA approval · 2024-02-29FDA Approved: VARENICLINE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved an original application for a generic varenicline product for smoking cessation, manufactured by Mylan Pharmaceuticals Inc.
-
CLINICAL_TRIALS research · 2024-02-21Clinical Trial Update: The Role of Nicotine and Non-Nicotine Alkaloids in E-Cigarette Use and Dependence [Phase 1, Phase 2]
Clinical trial exploring the role of nicotine and non-nicotine alkaloids in e-cigarette use and dependence across Phase 1 and Phase 2.